IRIS - Res&Arch Institutional Research Information System - Research & Archive

BIANCHI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.567
EU - Europa 2.828
AS - Asia 2.476
SA - Sud America 441
AF - Africa 73
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 9.391
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.516
SG - Singapore 1.186
IT - Italia 559
UA - Ucraina 399
IE - Irlanda 394
CN - Cina 359
BR - Brasile 335
SE - Svezia 294
HK - Hong Kong 292
VN - Vietnam 283
RU - Federazione Russa 269
DE - Germania 220
FR - Francia 184
FI - Finlandia 140
RO - Romania 113
GB - Regno Unito 93
IN - India 75
KR - Corea 58
AR - Argentina 45
BD - Bangladesh 34
CZ - Repubblica Ceca 33
TR - Turchia 33
BE - Belgio 25
IQ - Iraq 24
PL - Polonia 24
CA - Canada 23
CH - Svizzera 18
CO - Colombia 18
PK - Pakistan 17
EC - Ecuador 16
MX - Messico 16
CI - Costa d'Avorio 15
NL - Olanda 15
UZ - Uzbekistan 15
ZA - Sudafrica 15
ID - Indonesia 13
JP - Giappone 13
AT - Austria 11
GR - Grecia 11
PH - Filippine 11
ES - Italia 10
MA - Marocco 9
LB - Libano 8
SA - Arabia Saudita 8
VE - Venezuela 8
PE - Perù 7
TN - Tunisia 7
IL - Israele 6
AZ - Azerbaigian 5
EG - Egitto 5
JO - Giordania 5
LT - Lituania 5
PS - Palestinian Territory 5
ET - Etiopia 4
EU - Europa 4
PY - Paraguay 4
BO - Bolivia 3
CL - Cile 3
DZ - Algeria 3
GE - Georgia 3
KE - Kenya 3
MY - Malesia 3
NG - Nigeria 3
OM - Oman 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
LC - Santa Lucia 2
LR - Liberia 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
TH - Thailandia 2
UY - Uruguay 2
AU - Australia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CU - Cuba 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
MN - Mongolia 1
MR - Mauritania 1
MZ - Mozambico 1
Totale 9.386
Salva come PNG Salva come JPEG
Città #
Singapore 879
Chandler 427
Dublin 394
Perugia 326
Hong Kong 288
San Jose 232
San Mateo 232
Jacksonville 191
Ashburn 157
Boardman 157
Dong Ket 135
Santa Clara 127
Bucharest 111
Beijing 98
Wilmington 97
Medford 94
Princeton 93
Moscow 91
Altamura 89
Redmond 89
Munich 82
Lauterbourg 80
Ann Arbor 77
Andover 70
Des Moines 70
Lawrence 68
Seoul 57
Ho Chi Minh City 56
Los Angeles 53
New York 49
Falls Church 45
The Dalles 35
Dearborn 34
São Paulo 32
Turku 32
Hanoi 30
Orem 30
Woodbridge 28
Chennai 26
Pisa 26
Saint Petersburg 26
Brussels 25
Norwalk 22
Helsinki 21
Dallas 20
Piscataway 20
Brno 18
Council Bluffs 18
Frankfurt am Main 17
Warsaw 17
Boston 16
Fremont 16
Nuremberg 16
Abidjan 15
Brooklyn 15
Chicago 15
San Paolo di Civitate 14
Milan 13
Olomouc 13
Poplar 13
Tokyo 12
Denver 11
Izmir 11
Shanghai 11
Atlanta 10
Baghdad 10
Guangzhou 10
Haiphong 10
London 10
Manchester 10
Belo Horizonte 9
Johannesburg 9
Mumbai 9
San Diego 9
San Francisco 9
Seattle 9
Phoenix 8
Fortaleza 7
Medellín 7
Nanjing 7
Ankara 6
Buenos Aires 6
Columbus 6
Den Haag 6
Hanover 6
Houston 6
Istanbul 6
Jinan 6
Joinville 6
Montreal 6
Nagpur 6
Paris 6
Rio de Janeiro 6
Stockholm 6
Tashkent 6
Tianjin 6
Wuhan 6
Cape Town 5
Chengdu 5
Da Nang 5
Totale 5.942
Salva come PNG Salva come JPEG
Nome #
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 211
A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression. 202
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 202
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 191
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 190
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 181
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 181
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 173
87P - Towards the identification of the mechanism of action of antitumor 1-methyl-D-tryptophan 156
IL‐35Ig–expressing dendritic cells induce tolerance via Arginase 1 151
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 150
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 146
A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815. 146
CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide 144
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 141
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 139
The TGF-β/IDO axis in infectious tolerance. 134
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 134
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. 130
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 127
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 125
Antigen-specific immunoregulation by IL-35Ig-transfected dendritic cells 125
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 123
Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. 122
Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis 121
Ectopic expression of IL-35Ig by dendritic cells induces tolerance via Arginase 1. 119
[Experimental models of immunochemotherapeutic synergism: study of the influence of the treatment schedule]. 117
CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig. 117
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice 116
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 116
[Transfer in vivo of cytotoxic immune lymphocytes obtained in vitro in primary culture against a murine lymphoma antigenically altered by DTIC]. 116
Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. 114
IL-12 acts selectively on CD8a- dendritic cells to enhance presentation of a tumor peptide in vivo 112
Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation 111
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 110
Adoptive immunotherapy of intracerebral murine lymphomas: role of different lymphoid populations. 110
CD40 ligand and CTLA-4 are reciprocally regulated in the Th1 cell proliferative response sustained by CD8+ dendritic cells. 107
A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state 105
O6-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cell immunogenicity in murine L1210 leukemia 105
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. 102
Modulation of tryptophan catabolism by regulatory T cells 101
Immunobiological aspects of the nude mouse model relative to human cancer chemosensitivity tests. 101
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells 98
Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12 97
Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine 96
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. 96
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice 96
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 96
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. 95
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 94
Towards the identification of a tolerogenic signature in IDO-competent dendritic cells 93
CTLA-4-Ig regulates tryptophan catabolism in vivo. 92
T cell apoptosis by tryptophan catabolism 92
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 91
Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. 89
Use of a skin test assay to determine tumor-specific CD8+ T cell reactivity 87
Immunomodulatory properties of ribavirin in the mouse. 85
IL-12 induces SDS-stable class II (alpha beta) dimers in murine dendritic cells 85
Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement 85
IL-12 ACTS DIRECTLY ON DC TO PROMOTE NUCLEAR LOCALIZATION OF NF-kB AND PRIMES DC FOR IL-12 PRODUCTION 85
Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization. 84
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells 84
Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. 83
Tryptophan catabolism generates autoimmune-preventive regulatory T cells 83
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 82
IL-23 and IL-12 have overlapping but distinct effects on murine dendritic cells. 81
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 81
Drug-induced immunogenic changes of murine leukemia cells: dissociation of onset of resistance and emergence of novel immunogenicity. 80
Dendritic cells, CD4+ lymphocytes and IL-12 in an experimental model of antitumor immunotherapy 79
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma 79
Systemic adoptive immunotherapy of a highly immunogenic murine lymphoma growing in the brain. 79
Immunogenic properties of retroviral protein p15E from drug-treated murine mastocytoma P815 77
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. 77
Inhibition of murine lymphoma growth by adoptive transfer of lymphocytes sensitized to a xenogenized tumor variant. 77
Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex 76
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 74
IL-12 is both required and sufficient for initiating T-cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells 73
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 72
Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo. 71
Tumor-specific L3T4+ and Lyt-2+ lymphocytes in mice primed to mutagenized cell variants. 70
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 66
Dendritic cells and interleukin 12 as adjuvants for tumor-specific vaccines. 65
Induction of tumor suppression and delayed-type footpad reaction by transfer of lymphocytes sensitized to a xenogenized tumor variant. 60
Molecular and genomic aspects of xenogenizing-alkylating drugs. 60
PROTEASOME INHIBITION IN pDCs CONFERS AN IDO-DEPENDENT IMMUNOREGULATORY PHENOTYPE 59
O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents. 58
Tryptophan catabolism in nonobese diabetic mice. 58
Indoleamine 2,3-dioxygenase: from catalyst to signaling function 55
IFN-gamma inhibits presentation of a tumor/self peptide by CD8 alpha- dendritic cells via potentation of the CD8 alpha+ subset 52
Indoleamine 2,3 dioxygnenase: as an inducer and amplifier of regulatory T cell functions. 48
Th1 and Th2 cell clones to poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo 47
IDO-TARGETING INTERVENTION IN AUTOIMMUNE DIABETES BY PROTEASOME INHIBITION 46
The role of IL-12 in the induction of an immune response to a tumor/self peptide: prevention and reversion of anergy. 37
Totale 9.649
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.905
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.905
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021261 0 0 0 0 0 0 0 0 0 41 69 151
2021/20221.141 15 160 12 52 56 32 14 277 108 88 107 220
2022/20231.462 107 249 15 116 137 187 0 77 515 5 41 13
2023/2024559 35 85 15 9 3 9 150 17 50 12 63 111
2024/20251.340 23 113 98 72 160 62 47 88 231 85 208 153
2025/20263.045 189 240 161 421 365 315 535 229 327 263 0 0
Totale 9.649